Valeant Pharmaceuticals Complains to SEC Over Allergan Claims -CNBC

By Dow Jones Business News, 
A A A


Valeant Pharmaceuticals International Inc. (VRX.T) and Bill Ackman's Pershing Square have filed a complaint with the Securities and Exchange Commission over claims that Allergan has been misleading investors by making false and misleading statements about Valeant, CNBC reported Monday.

Specifically, Valeant is objecting to Allergan claims that Valeant has stagnant or declining sales in its Bausch and Lomb business unit, CNBC said.

Robert Khuzami, former head of enforcement of the SEC, is leading the effort for Valeant and Pershing Square, the report said, and separately they have gone to regulators in Quebec to file complaints.

Full story at www.cnbc.com

Write to nymonitoring@dowjones.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


  (END) Dow Jones Newswires
  07-21-140742ET
  Copyright (c) 2014 Dow Jones & Company, Inc.


This article appears in: News Headlines

Referenced Stocks: AGN , VRX

Dow Jones Business News


More from Dow Jones Business News:

Related Videos

Finding Heart in an Organ
Finding Heart in an Organ           

Stocks

Referenced

Most Active by Volume

113,378,902
  • $16.79 ▲ 1.33%
89,763,454
  • $7 ▲ 6.54%
67,512,111
  • $42.88 ▲ 3.93%
60,846,215
  • $101.66 ▲ 0.23%
52,286,887
  • $16.38 ▼ 7.09%
42,129,258
  • $52.19 ▲ 2.98%
36,281,096
  • $46.695 ▼ 0.65%
31,634,172
  • $25.16 ▼ 0.08%
As of 9/12/2014, 04:15 PM